Nanosonics Limited (OTCMKTS:NNCSF – Get Free Report) shares were down 17.2% during mid-day trading on Friday . The stock traded as low as $2.01 and last traded at $2.07. Approximately 3,438 shares were traded during mid-day trading, an increase of 155% from the average daily volume of 1,349 shares. The stock had previously closed at $2.50.
Nanosonics Stock Performance
The business has a 50-day moving average price of $2.52 and a 200 day moving average price of $2.55.
Nanosonics Company Profile
Nanosonics Limited is an Australia?based medical technology company specializing in infection prevention solutions for the healthcare sector. Founded in 2001 and headquartered in Sydney, the company is best known for developing and commercializing its proprietary Trophon platform, which provides automated high?level disinfection of ultrasound probes using sonically activated hydrogen peroxide vapor. Nanosonics holds numerous patents and regulatory approvals across multiple jurisdictions, positioning it as a leader in point?of?care decontamination.
The company’s flagship product, Trophon EPR, is designed to address the critical need for rapid, reliable disinfection of endocavity and surface ultrasound transducers.
Recommended Stories
- Five stocks we like better than Nanosonics
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for Nanosonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanosonics and related companies with MarketBeat.com's FREE daily email newsletter.
